Platinum (cisplatin is named as a drug or biological intervention in 2 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. (1) and Jiangsu Hansoh Pharmaceutical Co., Ltd. (1). Registered phases: Phase 1/2 and Phase 1. Conditions studied include SCLC, Extensive Stage; Advanced Solid Tumors; Colorectal Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07136285 | Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC (ClinicalTrials.gov ↗) SCLC, Extensive Stage |
Phase 1/2 | Recruiting |
| NCT06963502 | A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors (ClinicalTrials.gov ↗) Advanced Solid Tumors, Colorectal Cancer, Non-Small Cell Lung Cancer |
Phase 1 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| SCLC, Extensive Stage | 1 |
| Advanced Solid Tumors | 1 |
| Colorectal Cancer | 1 |
| Non-Small Cell Lung Cancer | 1 |
| Lead sponsor | Trials |
|---|---|
| Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. | 1 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 1 |
| Register | Platinum (cisplatin trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Platinum (cisplatin works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Platinum (cisplatin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.